ALZHEIMER DISEASE & ASSOCIATED DISORDERS : Impact Factor & More
eISSN: 0893-0341pISSN: 0893-0341
Share this on:
Key Metrics
Impact Factor 
< 5
SJR
Q2Gerontology
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on ALZHEIMER DISEASE & ASSOCIATED DISORDERS
ALZHEIMER DISEASE & ASSOCIATED DISORDERS Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | LIPPINCOTT WILLIAMS & WILKINS |
| Language | English |
| Frequency | Quarterly |
| General Details | |
| Language | English |
| Frequency | Quarterly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in ALZHEIMER DISEASE & ASSOCIATED DISORDERS ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in ALZHEIMER DISEASE & ASSOCIATED DISORDERS
CHMP2B p.Ala30Ser Variant in Biomarker-Confirmed Early-Onset Alzheimer Disease: A Potential Endolysosomal Disease Modifier.
- 4 Jun 2026
- Alzheimer disease and associated disorders
Risk of Alzheimer Disease and Other Dementias in Patients With Parkinson Disease: A Nationwide Cohort Study.
- 6 May 2026
- Alzheimer disease and associated disorders
Survey of Mobile Phone Usage Among Patients With Cognitive Impairment.
- 13 Apr 2026
- Alzheimer disease and associated disorders
Association Between Engagement and Agitation in Dementia: Clinical and Environmental Factors in Nonpharmacological Therapy.
- 30 Mar 2026
- Alzheimer disease and associated disorders
Validity of the Montreal Cognitive Assessment-Basic (MoCA-B) in a Dutch Memory Clinic.
- 1 Feb 2026
- Alzheimer disease and associated disorders
Pupillometry as a Differential Indicator of Cognitive Processing in Alzheimer Disease and Behavioral Variant Frontotemporal Dementia.
- 1 Feb 2026
- Alzheimer disease and associated disorders
CHMP2B p.Ala30Ser Variant in Biomarker-Confirmed Early-Onset Alzheimer Disease: A Potential Endolysosomal Disease Modifier.
- 4 Jun 2026
- Alzheimer disease and associated disorders
Risk of Alzheimer Disease and Other Dementias in Patients With Parkinson Disease: A Nationwide Cohort Study.
- 6 May 2026
- Alzheimer disease and associated disorders
Survey of Mobile Phone Usage Among Patients With Cognitive Impairment.
- 13 Apr 2026
- Alzheimer disease and associated disorders
Association Between Engagement and Agitation in Dementia: Clinical and Environmental Factors in Nonpharmacological Therapy.
- 30 Mar 2026
- Alzheimer disease and associated disorders
Validity of the Montreal Cognitive Assessment-Basic (MoCA-B) in a Dutch Memory Clinic.
- 1 Feb 2026
- Alzheimer disease and associated disorders
Pupillometry as a Differential Indicator of Cognitive Processing in Alzheimer Disease and Behavioral Variant Frontotemporal Dementia.
- 1 Feb 2026
- Alzheimer disease and associated disorders
FAQs on ALZHEIMER DISEASE & ASSOCIATED DISORDERS
How long has ALZHEIMER DISEASE & ASSOCIATED DISORDERS been actively publishing? 
What is the publishing frequency of ALZHEIMER DISEASE & ASSOCIATED DISORDERS?
How many articles did ALZHEIMER DISEASE & ASSOCIATED DISORDERS publish last year?
What is the eISSN & pISSN for ALZHEIMER DISEASE & ASSOCIATED DISORDERS?
What is the SJR for ALZHEIMER DISEASE & ASSOCIATED DISORDERS?
Who is the publisher of ALZHEIMER DISEASE & ASSOCIATED DISORDERS?
